Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€176.00

€176.00

-1.680%
-3.0
-1.680%
€175.00

€175.00

 
Latest predictions
-
28.08.20
€175.00
15.07.20
buy
Your prediction

Icon plc Stock

We can see a decrease in the price for Icon plc. Compared to yesterday it has lost -€3.000 (-1.680%).
With 1 Sell predictions and 1 Buy predictions the community sentiment towards the Icon plc stock is not clear.
With a current price of €176.00 Icon plc is right around the predicted target price of €175.00.

Pros and Cons of Icon plc in the next few years

Pros
?
Market Position
?
Conscious of the environment
?
Worthwhile Investment for the next years
Cons
?
Shareholder structure
?
Brand
?
Growth compared to competition
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Icon plc vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Icon plc -1.680% 2.326% 10.692% 11.392% 12.821% 98.870% 185.136%
Alkermes plc -1.670% -4.839% -0.562% 10.625% 1.724% - -
Invitae Corp -6.060% 4.181% 8.454% 169.940% 25.519% - -
Halozyme Therapeutics Inc. -2.190% 3.617% 16.395% 135.145% 17.166% - -

Other discussions about Icon plc Stock

New thread Forum

News

ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference


ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health

ICON Releases First Environmental, Social and Governance Report: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Releases First Environmental, Social and Governance Report


ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health

ICON plc to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference : https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON plc to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference


ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health

ICON Reports Third Quarter 2020 Results : https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Reports Third Quarter 2020 Results


ICON plc (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health

ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference


ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health